To meet the growing need for innovative, long-term solutions to the global burden of vector-borne diseases, the Institute of Vector-Borne Disease (IVBD) is expanding and diversifying its research portfolio.
The IVBD’s research focuses on the following discovery and translational themes:
- The implementation of Wolbachia for biocontrol of arbovirus transmission
- Wolbachia new product development and mechanistic biology in the context of arboviral disease control
- Clinical research in endemic countries to measure the impact of interventions and illuminate the natural history of arboviral infections in humans and mosquitoes
- Innovative and cutting-edge discovery projects with potentially high reward
Our primary research themes are supported by expertise in the following cross-cutting disciplines:
- Clinical research
- Molecular biology
The World Mosquito Program
The IVBD’s flagship research program is the World Mosquito Program (WMP), a global not-for-profit initiative working to protect communities from mosquito-borne diseases. The WMP uses naturally occurring Wolbachia bacteria to reduce the ability of mosquitoes to transmit viruses such as Zika, dengue and chikungunya. Based at Monash University's Clayton Campus, the WMP's Oceania hub supports projects in the region and contributes to core global operations.
Following years of laboratory research into Wolbachia, the WMP began conducting field trials in 2011. Widespread support from communities, governments and regulators has enabled the WMP to expand its projects to 12 countries around the world.